The OPEN MINDS Executive Blueprint For Crisis Management: Building Organizational Sustainability & Success In A Disrupted Health & Human Service Market
A 32-week program designed to help executive teams navigate the business, organizational, operational, and culture changes of a market in turbulence. The program, based on the seven-component OPEN MINDS Executive Blueprint, combines a series of 35 live web briefings with online technical assistance and a suite of on-demand resources.
Genetic Biomarkers Predict Antidepressant Response; Genetic Switch May Cause Depression Brain Changes
Researchers have identified genetic biomarkers that indicate whether a person will respond favorably to specific antidepressant medications. A separate research finding identified a genetic switch implicated in cognitive problems associated with depression.
The work with genetic biomarkers found that after eight weeks of treatment, the patients who had not responded were those who had higher levels of three inflammation markers before treatment started than patients who responded. The biomarkers are not specific to one or the other antidepressants, so could not be used to guide the choice of antidepressants, but could identify patients that potentially may be . . .